126 related articles for article (PubMed ID: 38167595)
1. Comparison in Detection Rate of Clinically Significant Prostate Cancer Between Microultrasound-guided Prostate Biopsy (ExactVu) and Multiparametric Resonance Imaging-guided Prostate Biopsy (Koelis System).
García Rojo E; García Gómez B; Sopeña Sutil R; Vallejo Arzayus D; Justo Quintas J; García Barreras S; Brime Menéndez R; Peña Vallejo E; Calzas Montalvo C; López Curtis D; Bozzini G; Romero Otero J
Urology; 2024 Jan; 183():163-169. PubMed ID: 38167595
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Diagnostic Accuracy of Micro-ultrasound and Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies for the Diagnosis of Clinically Significant Prostate Cancer.
Lughezzani G; Saita A; Lazzeri M; Paciotti M; Maffei D; Lista G; Hurle R; Buffi NM; Guazzoni G; Casale P
Eur Urol Oncol; 2019 May; 2(3):329-332. PubMed ID: 31200848
[TBL] [Abstract][Full Text] [Related]
3. Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy: A Prospective Randomized Trial.
Saner YM; Wiesenfarth M; Weru V; Ladyzhensky B; Tschirdewahn S; Püllen L; Bonekamp D; Reis H; Krafft U; Heß J; Kesch C; Darr C; Forsting M; Wetter A; Umutlu L; Haubold J; Hadaschik B; Radtke JP
Eur Urol Oncol; 2023 Feb; 6(1):49-55. PubMed ID: 36175281
[TBL] [Abstract][Full Text] [Related]
4. A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk.
Miah S; Hosking-Jervis F; Connor MJ; Eldred-Evans D; Shah TT; Arya M; Barber N; Bhardwa J; Bott S; Burke D; Doherty A; Foster C; Freeman A; Hindley R; Jameson C; Karim O; Laniado M; Montgomery B; Nigam R; Punwani S; Sinclair A; Winkler M; Allen C; Ahmed HU
Eur Urol Oncol; 2020 Jun; 3(3):262-269. PubMed ID: 31411968
[TBL] [Abstract][Full Text] [Related]
5. Evolution of Targeted Prostate Biopsy by Adding Micro-Ultrasound to the Magnetic Resonance Imaging Pathway.
Wiemer L; Hollenbach M; Heckmann R; Kittner B; Plage H; Reimann M; Asbach P; Friedersdorff F; Schlomm T; Hofbauer S; Cash H
Eur Urol Focus; 2021 Nov; 7(6):1292-1299. PubMed ID: 32654967
[TBL] [Abstract][Full Text] [Related]
6. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
Boschheidgen M; Albers P; Schlemmer HP; Hellms S; Bonekamp D; Sauter A; Hadaschik B; Krilaviciute A; Radtke JP; Seibold P; Lakes J; Arsov C; Gschwend JE; Herkommer K; Makowski M; Kuczyk MA; Wacker F; Harke N; Debus J; Körber SA; Benner A; Kristiansen G; Giesel FL; Antoch G; Kaaks R; Becker N; Schimmöller L
Eur Urol; 2024 Feb; 85(2):105-111. PubMed ID: 37863727
[TBL] [Abstract][Full Text] [Related]
8. Growth Patterns of Prostate Cancers Undetected by Prostate 3T Multiparametric MRI.
Chang KP; Hsieh PF; Lin WC; Chang H
In Vivo; 2024; 38(2):833-841. PubMed ID: 38418107
[TBL] [Abstract][Full Text] [Related]
9. Fusion-targeted biopsy significantly improves prostate cancer detection in biopsy-naïve men.
Blas L; Shiota M; Tsukahara S; Goto S; Kinoshita F; Matsumoto T; Monji K; Kashiwagi E; Inokuchi J; Eto M
Int J Urol; 2023 Jul; 30(7):600-604. PubMed ID: 37078488
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Magnetic Resonance Imaging/Ultrasound-guided Target Biopsy in Detecting Clinically Significant Prostate Cancer.
Kurokawa G; Mori K; Sasaki H; Nakano J; Takahashi Y; Iwatani K; Urabe F; Tsuzuki S; Koike Y; Sato S; Takahashi H; Miki K; Kimura T
Anticancer Res; 2024 Feb; 44(2):679-686. PubMed ID: 38307559
[TBL] [Abstract][Full Text] [Related]
11. The Microultrasound-Guided Prostate Biopsy in Detection of Prostate Cancer: A Systematic Review and Meta-Analysis.
You C; Li X; Du Y; Peng L; Wang H; Zhang X; Wang A
J Endourol; 2022 Mar; 36(3):394-402. PubMed ID: 34569293
[No Abstract] [Full Text] [Related]
12. Diagnostic performance of microUltrasound at MRI-guided confirmatory biopsy in patients under active surveillance for low-risk prostate cancer.
Maffei D; Fasulo V; Avolio PP; Saitta C; Paciotti M; De Carne F; Colombo P; Pasini L; De Zorzi SZ; Saita A; Hurle R; Lazzeri M; Guazzoni GF; Casale P; Buffi NM; Lughezzani G
Prostate; 2023 Jun; 83(9):886-895. PubMed ID: 36960788
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.
Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D
J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846
[TBL] [Abstract][Full Text] [Related]
14. Cognitive versus Software-Assisted Registration: Development of a New Nomogram Predicting Prostate Cancer at MRI-Targeted Biopsies.
Kaufmann S; Russo GI; Thaiss W; Notohamiprodjo M; Bamberg F; Bedke J; Morgia G; Nikolaou K; Stenzl A; Kruck S
Clin Genitourin Cancer; 2018 Aug; 16(4):e953-e960. PubMed ID: 29685613
[TBL] [Abstract][Full Text] [Related]
15. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO
Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981
[TBL] [Abstract][Full Text] [Related]
16. Prostate Mapping for Cancer Diagnosis: The Madrid Protocol. Transperineal Prostate Biopsies Using Multiparametric Magnetic Resonance Imaging Fusion and Micro-Ultrasound Guided Biopsies.
Rodríguez Socarrás ME; Gomez Rivas J; Cuadros Rivera V; Reinoso Elbers J; Llanes González L; Michel Mercado I; Fernandez Del Alamo J; Juarez Del Dago P; Sancha FG
J Urol; 2020 Oct; 204(4):726-733. PubMed ID: 32314932
[TBL] [Abstract][Full Text] [Related]
17. Detection of prostate cancer using magnetic resonance imaging/ultrasonography image-fusion targeted biopsy in African-American men.
Shin T; Smyth TB; Ukimura O; Ahmadi N; de Castro Abreu AL; Oishi M; Mimata H; Gill IS
BJU Int; 2017 Aug; 120(2):233-238. PubMed ID: 28111879
[TBL] [Abstract][Full Text] [Related]
18. Use of Prostate Specific Antigen Density Combined with Multiparametric Magnetic Resonance Imaging Improves Triage for Prostate Biopsy.
Záleský M; Stejskal J; Adamcova V; Hrbáček J; Minarik I; Pavlicko A; Votrubova J; Babjuk M; Zachoval R
Urol Int; 2019; 103(1):33-40. PubMed ID: 31067560
[TBL] [Abstract][Full Text] [Related]
19. Impact of real-time elastography on magnetic resonance imaging/ultrasound fusion guided biopsy in patients with prior negative prostate biopsies.
Brock M; Löppenberg B; Roghmann F; Pelzer A; Dickmann M; Becker W; Martin-Seidel P; Sommerer F; Schenk L; Palisaar RJ; Noldus J; von Bodman C
J Urol; 2015 Apr; 193(4):1191-7. PubMed ID: 25451832
[TBL] [Abstract][Full Text] [Related]
20. Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate Biopsies.
Maxeiner A; Nest AM; Stephan C; Cash H; Baur ADJ; Fischer T; Kilic E; Piper SK; Nowak CP; Busch J; Miller K; Mang J
Urol Int; 2020; 104(3-4):205-213. PubMed ID: 31801153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]